Stillwater, OK, United States of America

Erika Lutter

This inventor holds 1 USPTO granted patent. Top assignee: Board of Regents for the Oklahoma Agricultural & Mechanical Colleges. Active years: 2023.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovator Spotlight: Erika Lutter, Pioneering Antimicrobial Solutions

Introduction:

Erika Lutter, a talented inventor hailing from Stillwater, OK (US), has made significant contributions to the field of antimicrobial technologies with her groundbreaking patent - the Melanin-inspired antimicrobial.

Latest Patents:

Erika Lutter's innovative patent involves the development of a Eumelanin-inspired antimicrobial that demonstrates remarkable efficacy against methicillin-resistant Staphylococcus aureus (MRSA). By incorporating quaternary ammonium functionalized “arms” onto a Eumelanin-inspired indole, she has engineered a potent cell wall destroying antimicrobial agent with inherent antifungal properties.

Career Highlights:

Erika Lutter is a valued member of the Board of Regents for the Oklahoma Agricultural & Mechanical Colleges, where she continues to drive innovation and excellence in her field. Her relentless pursuit of solutions for combating antibiotic-resistant strains showcases her commitment to public health and scientific advancement.

Collaborations:

Throughout her career, Erika Lutter has collaborated closely with esteemed colleagues such as Toby Larue Nelson and Santosh Adhikari. Together, they have worked on pioneering Eumelanin-inspired phenyleneethynylene (EIPE) derivatives like EIPE-1 and EIPE-HCl, which exhibit promising antibacterial properties against a range of gram-positive organisms.

Conclusion:

Erika Lutter's trailblazing work in the realm of antimicrobial research stands as a testament to her ingenuity and dedication. Her inventive spirit and collaborative efforts continue to shape the landscape of healthcare innovations, offering hope for a future with more effective antimicrobial solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…